AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...

Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...

Unchecked artificial intelligence may soon outthink, outmaneuver, and eventually replace human beings — unless we impose real ...

Previous Community Perspectives have described threats posed by Artificial Intelligence (AI) and its convergence with the rapidly expanding technological ecosystem — especially nanotechnology, ...

Merlin Egalite, co-founder of Morpho Labs, addressed the issue of temporary liquidity shortages in certain Morpho vaults on ...

By any measure, there is an enormous number of programming languages. Some lists contain hundreds, while the Historical ...

A new physics study challenges the simulation hypothesis, arguing that the universe contains realities that can likely never ...

Gibson highlighted, "Recursion has a tremendous amount of potential catalysts coming in the next 18 months," referencing the pipeline, partnerships, and platform advancements. He reported, "a pro ...

Salt Lake City, Utah, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced that its Board ...

The amygdala is part of the limbic system, which regulates emotional and behavioral responses. An amygdala hijack is a fight-or-flight response to stress. To better understand what an amygdala hijack ...